docetaxel anhydrous has been researched along with urea in 5 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (urea) | Trials (urea) | Recent Studies (post-2010) (urea) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 45,450 | 2,047 | 9,188 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisonni, R; Calvani, M; D'Iddio, S; Graziano, F; Lippe, P; Mancinelli, A | 1 |
| Bilim, V; Billadeau, D; Kawazoe, H; Motoyama, T; Muto, A; Naito, S; Ougolkov, A; Oya, M; Tomita, Y; Yuuki, K | 1 |
| Cooke, LS; Liu, X; Mahadevan, D; Miller, TP; Persky, DO; Qi, W; Squires, M | 1 |
| Kopeček, J; Kopečková, P; Peng, ZH; Salama, ME; Sima, M | 1 |
| Amini, M; Atyabi, F; Dinarvand, R; Goodarzi, N; Saeedian Moghadam, E; Saniee, F; Shabani Ravari, N | 1 |
1 trial(s) available for docetaxel anhydrous and urea
| Article | Year |
|---|---|
Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.
Topics: Acetylcarnitine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carnitine; Chromatography, High Pressure Liquid; Creatinine; Docetaxel; Female; Glucose; Humans; Infusions, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Paclitaxel; Phosphates; Taxoids; Urea; Vinblastine; Vinorelbine | 2007 |
4 other study(ies) available for docetaxel anhydrous and urea
| Article | Year |
|---|---|
Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Renal Cell; Cell Proliferation; Cell Survival; Docetaxel; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Kidney Neoplasms; Male; Middle Aged; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Taxoids; Thiazoles; Urea; X-Linked Inhibitor of Apoptosis Protein | 2009 |
AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aurora Kinase B; Aurora Kinases; Benzimidazoles; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Docetaxel; Humans; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Mice; Mice, SCID; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Taxoids; Urea; Xenograft Model Antitumor Assays | 2012 |
Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specific membrane antigen expressing prostate cancer.
Topics: Acrylamides; Adenocarcinoma; Animals; Antigens, Surface; Antineoplastic Agents; Cell Line, Tumor; Delayed-Action Preparations; Docetaxel; Drug Delivery Systems; Glutamate Carboxypeptidase II; Glutarates; Humans; Male; Mice; Mice, Nude; Molecular Weight; Oligopeptides; Polymers; Prostatic Neoplasms; Taxoids; Urea; Xenograft Model Antitumor Assays | 2013 |
Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel.
Topics: Antigens, Surface; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Docetaxel; Drug Carriers; Drug Delivery Systems; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Inhibitory Concentration 50; Male; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglactin 910; Prostatic Neoplasms; Time Factors; Urea | 2021 |